415 related articles for article (PubMed ID: 19574547)
1. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
Marston S; Copeland O; Jacques A; Livesey K; Tsang V; McKenna WJ; Jalilzadeh S; Carballo S; Redwood C; Watkins H
Circ Res; 2009 Jul; 105(3):219-22. PubMed ID: 19574547
[TBL] [Abstract][Full Text] [Related]
2. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
[TBL] [Abstract][Full Text] [Related]
3. Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathy.
Helms AS; Davis FM; Coleman D; Bartolone SN; Glazier AA; Pagani F; Yob JM; Sadayappan S; Pedersen E; Lyons R; Westfall MV; Jones R; Russell MW; Day SM
Circ Cardiovasc Genet; 2014 Aug; 7(4):434-43. PubMed ID: 25031304
[TBL] [Abstract][Full Text] [Related]
4. Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy.
Helms AS; Tang VT; O'Leary TS; Friedline S; Wauchope M; Arora A; Wasserman AH; Smith ED; Lee LM; Wen XW; Shavit JA; Liu AP; Previs MJ; Day SM
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877118
[TBL] [Abstract][Full Text] [Related]
5. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue.
Wijnker PJ; Friedrich FW; Dutsch A; Reischmann S; Eder A; Mannhardt I; Mearini G; Eschenhagen T; van der Velden J; Carrier L
J Mol Cell Cardiol; 2016 Aug; 97():82-92. PubMed ID: 27108529
[TBL] [Abstract][Full Text] [Related]
7. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.
van Dijk SJ; Dooijes D; dos Remedios C; Michels M; Lamers JM; Winegrad S; Schlossarek S; Carrier L; ten Cate FJ; Stienen GJ; van der Velden J
Circulation; 2009 Mar; 119(11):1473-83. PubMed ID: 19273718
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.
Barefield D; Kumar M; Gorham J; Seidman JG; Seidman CE; de Tombe PP; Sadayappan S
J Mol Cell Cardiol; 2015 Feb; 79():234-43. PubMed ID: 25463273
[TBL] [Abstract][Full Text] [Related]
9. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.
Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB
J Mol Cell Cardiol; 2008 Aug; 45(2):209-16. PubMed ID: 18573260
[TBL] [Abstract][Full Text] [Related]
10. Spatial and Functional Distribution of
Helms AS; Thompson AD; Glazier AA; Hafeez N; Kabani S; Rodriguez J; Yob JM; Woolcock H; Mazzarotto F; Lakdawala NK; Wittekind SG; Pereira AC; Jacoby DL; Colan SD; Ashley EA; Saberi S; Ware JS; Ingles J; Semsarian C; Michels M; Olivotto I; Ho CY; Day SM
Circ Genom Precis Med; 2020 Oct; 13(5):396-405. PubMed ID: 32841044
[TBL] [Abstract][Full Text] [Related]
11. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.
Glazier AA; Thompson A; Day SM
Pflugers Arch; 2019 May; 471(5):781-793. PubMed ID: 30456444
[TBL] [Abstract][Full Text] [Related]
13. Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.
Parbhudayal RY; Garra AR; Götte MJW; Michels M; Pei J; Harakalova M; Asselbergs FW; van Rossum AC; van der Velden J; Kuster DWD
J Mol Cell Cardiol; 2018 Oct; 123():59-63. PubMed ID: 30170119
[TBL] [Abstract][Full Text] [Related]
14. MYBPC3-c.772G>A mutation results in haploinsufficiency and altered myosin cycling kinetics in a patient induced stem cell derived cardiomyocyte model of hypertrophic cardiomyopathy.
Steczina S; Mohran S; Bailey LRJ; McMillen TS; Kooiker KB; Wood NB; Davis J; Previs MJ; Olivotto I; Pioner JM; Geeves MA; Poggesi C; Regnier M
J Mol Cell Cardiol; 2024 Jun; 191():27-39. PubMed ID: 38648963
[TBL] [Abstract][Full Text] [Related]
15. Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human
Pioner JM; Vitale G; Steczina S; Langione M; Margara F; Santini L; Giardini F; Lazzeri E; Piroddi N; Scellini B; Palandri C; Schuldt M; Spinelli V; Girolami F; Mazzarotto F; van der Velden J; Cerbai E; Tesi C; Olivotto I; Bueno-Orovio A; Sacconi L; Coppini R; Ferrantini C; Regnier M; Poggesi C
Circ Res; 2023 Mar; 132(5):628-644. PubMed ID: 36744470
[TBL] [Abstract][Full Text] [Related]
16. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
Seeger T; Shrestha R; Lam CK; Chen C; McKeithan WL; Lau E; Wnorowski A; McMullen G; Greenhaw M; Lee J; Oikonomopoulos A; Lee S; Yang H; Mercola M; Wheeler M; Ashley EA; Yang F; Karakikes I; Wu JC
Circulation; 2019 Feb; 139(6):799-811. PubMed ID: 30586709
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two murine models of familial hypertrophic cardiomyopathy.
McConnell BK; Fatkin D; Semsarian C; Jones KA; Georgakopoulos D; Maguire CT; Healey MJ; Mudd JO; Moskowitz IP; Conner DA; Giewat M; Wakimoto H; Berul CI; Schoen FJ; Kass DA; Seidman CE; Seidman JG
Circ Res; 2001 Mar; 88(4):383-9. PubMed ID: 11230104
[TBL] [Abstract][Full Text] [Related]
18. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.
McConnell BK; Jones KA; Fatkin D; Arroyo LH; Lee RT; Aristizabal O; Turnbull DH; Georgakopoulos D; Kass D; Bond M; Niimura H; Schoen FJ; Conner D; Fischman DA; Seidman CE; Seidman JG
J Clin Invest; 1999 Nov; 104(9):1235-44. PubMed ID: 10545522
[TBL] [Abstract][Full Text] [Related]
19. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype.
Kolokotronis K; Kühnisch J; Klopocki E; Dartsch J; Rost S; Huculak C; Mearini G; Störk S; Carrier L; Klaassen S; Gerull B
Hum Mutat; 2019 Aug; 40(8):1101-1114. PubMed ID: 30924982
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]